High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C.Maria Elisa Mancuso, Massimo Colombo, Silvia Linari et al.|PubMed|2006Cited by 25
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapyMaria Elisa Mancuso, Pier Mannuccio Mannucci, Maria Grazia Rumi et al.|Journal of Thrombosis and Haemostasis|2009Cited by 12
Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective StudyAntonio Coppola, Annarita Tagliaferri, Valeria Coluccio et al.|Journal of Clinical Medicine|2024Cited by 6